CME Group Inc. CME
Set alert
304.95 USD -1.29 -0.42%
As of Nov 3, 3:08 PM ET
300.93 Day range 306.53
218.58 52-week range 326.46
- YTD
- +11.67%
- 1 year
- +15.44%
- Open
- 306.11
- Prev close
- 306.24
- Mkt cap
- 109.15B
- Vol
- 938.15K
- Avg vol
- 1.92M
- EPS
- 12.20
- P/E
- 25.00
- Div yield
- 1.75%
More statistics
- Low
- 300.93
- High
- 306.53
- Forward P/E
- 23.15
- Beta
- 0.18
- Short ratio
- 2.65
- Inst. own
- 92.06%
- Dividend
- 5.20
- Ex-div date
- Sep 8, 2026
- Earnings
- Feb 3, 2027
- 50-d avg
- 280.33
- 200-d avg
- 280.19
- 1y target
- 317.06
3M chart
Events in this range
- Sep 9, 2026Dividend: 1.3
- Oct 21, 2026Earnings: 3.02; estimate 2.99; surprise 1%
- Oct 22, 2026Rating: JP Morgan · Underweight → Overweight
- Oct 22, 2026Rating: Piper Sandler · Overweight → Overweight
- Oct 22, 2026Rating: Wells Fargo · Overweight → Overweight
- Oct 22, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Oct 22, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 22, 2026Rating: UBS · Neutral → Neutral
Signals (12)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 2 months ago |
| RSI: Overbought | Aug 28, 2026 | 2 months ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 317.06 +4.0% upside
Now 304.95
- Target (low)
- 227.00
- Target (mean)
- 317.06
- Target (high)
- 367.00
Ratings (0m) 17 9 buy · 6 hold · 2 sell
- Strong buy5
- Buy4
- Hold6
- Sell1
- Strong sell1
Recommendation trend
- This month 17
- 1 month ago 16
- 2 months ago 16
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 3.03 | 2.92 – 3.28 | 2.77 | +9.2% | 1.76B | +6.9% | 14 |
| Next quarter | 3.32 | 3.05 – 3.60 | 3.36 | -1.2% | 1.86B | -1.1% | 12 |
| Current year | 12.40 | 12.29 – 12.66 | 11.20 | +10.7% | 7.09B | +8.7% | 15 |
| Next year | 13.23 | 12.38 – 13.70 | 12.40 | +6.7% | 7.46B | +5.2% | 16 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 22, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 22, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 22, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 22, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 22, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Oct 22, 2026 | JP Morgan | Upgrade | Underweight | Overweight |
| Oct 14, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 9, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 7, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 5, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 2, 2026 | Wells Fargo | Initiated | — | Overweight |
| Sep 28, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Sep 3, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Aug 19, 2026 | Deutsche Bank | Downgrade | Buy | Hold |
| Jul 23, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| Jul 23, 2026 | B of A Securities | Maintained | Underperform | Underperform |
| Jul 23, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 15, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 10, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 9, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 8, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 6, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 2, 2026 | Raymond James | Reiterated | Outperform | Outperform |
| Jun 22, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jun 18, 2026 | Keefe, Bruyette & Woods | Upgrade | Market Perform | Outperform |
| Jun 11, 2026 | Rothschild & Co | Upgrade | Neutral | Buy |
| Jun 5, 2026 | Erste Group | Downgrade | Buy | Hold |
| Apr 23, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Apr 23, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
